Corcept Therapeutics | CORT - 股本和储备



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.65B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


股本和储备 更改 日
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Ardelyx USD 148.62M 18.33M 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
J&J USD 84.97B 3.78B 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
Merck USD 41.93B 3.94B 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Novartis USD 41.95B 3.02B 2026-06
Novartis USD 38.93B 7.2B 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 671.98M 18.08M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
TG Therapeutics USD 604.08M 20.95M 2026-06